Bengaluru-based healthtech start-up NIRAMAI Health Analytix has raised about ₹43 crore ($6 million) in a Series A round led by Japanese VC firm Dream Incubator with participation from BEENEXT and other investors. Existing investors pi Ventures, Ankur Capital, Axilor Ventures and Binny Bansal also participated in this round. NIRAMAI will use the money to scale its operations in India, hire top talent and get additional regulatory approvals for international expansion. The company is using thermal imaging to detect breast cancer at an early stage. It had raised a seed round of over ₹7 crore ($1 million) in April 2017.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.